Mehmet BİLİCİ, Hilal ÖZMEN KIZILTUNÇ, Mustafa KANDAZ, Salim Başol TEKİN, Kerim ÇAYIR, Mustafa Vecdi ERTEKİN

The evaluation of the results of adjuvant chemoradiotherapy in patients with gastric cancer: results from a single center in eastern Anatolia

To evaluate the results of postoperative chemoradiotherapy in patients with gastric cancer. Gastric cancer is an important public health problem in Turkey, especially in the eastern Anatolia region. Surgery is the primary modality for managing early-stage disease, but most patients who undergo a curative resection develop locoregional or distant recurrence. Therefore, the administration of adjuvant treatment in gastric cancer has great importance. Materials and methods: Operated patients with stage IB-IV (M0) gastric cancer were enrolled in this study. A total of 148 patients with gastric cancer who had completed adjuvant chemoradiotherapy were evaluated retrospectively. Total overall survival (OS), disease-free survival (DFS), median survival, and 3- and 5-year survival were also determined. Results: Age, lymph node involvement, clinical stage, and surgical margin are prognostic factors that are significantly correlated with the duration of survival. Sex, smoking status, family history, the localization of the tumor, and the type of surgery were found to have no effects on the duration of survival. Tolerable side effects after administration of adjuvant chemotherapy were observed. The median OS and DFS of the patients were found to be 24.56 and 18.1 months, respectively. OS rates for 3- and 5-year survival were 38.3% and 27.6%, respectively. Conclusion: These findings suggest that adjuvant chemoradiotherapy is a highly effective and important treatment option in the overall survival of operated patients with gastric cancer.

Anahtar Kelimeler:

Key words: Gastric cancer, adjuvant chemoradiotherapy, survival, toxicity

The evaluation of the results of adjuvant chemoradiotherapy in patients with gastric cancer: results from a single center in eastern Anatolia

Keywords:

Key words: Gastric cancer, adjuvant chemoradiotherapy, survival, toxicity,

PDF

___

Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
Blaszkowsky LS. Mide kanseri [Gastric cancer]. In: Dönmez B, translator. Harrison onkoloji el kitabı. İstanbul: Nobel Tıp Kitapevleri; 2009. p.395-401 [Chabner BA, Lynch TJ, Longo DL, editors. Harrison’s manual of oncology. New York: McGraw Hill; 2008]. 7. National Cancer Institute. Protocol development. Washington DC: US National Institutes of Health; 2010. Available from: URL: http://ctep.cancer.gov/protocolDevelopment/electronic_ applications/ctc.htm#ctc_archive.
Jansen E, Boot H, Verheij M, van de Velde C. Optimal locoregional treatment in gastric cancer. J Clin Oncol 2005; 23: 4509-17.
Gunderson LL. Gastric carcinoma-patterns of relapse aft er surgical resection. Semin Radiat Oncol 2002; 12: 150-61.
Wanebo HJ, Kennedy BJ, Chmiel J, Steele G Jr, Winchester D, Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 1993; 218: 583-92.
Lehnert T, Rudek B, Buhl K, Golling M. Surgical therapy for loco-regional recurrence and distant metastasis of gastric cancer. Eur J Surg Oncol 2002; 28: 45-61.
Valentini V, Cellini F. Radiotherapy in gastric cancer: a systematic review of literature and new perspectives. Expert Rev Anticancer Th er 2007; 7: 1379-93.
Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333: 32-41.
Hazard L, O’Connor L, Scaife C. Role of radiation therapy in gastric adenocarcinoma. World J Gastroenterol 2006; 12: 1511
Moertel CG, Childs DS, O’Fallon JR, Holbrook MA, Schutt AJ, Reitemeier RJ. Combined 5-fl uorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. J Clin Oncol 1984; 2: 1249-54.
Al-Refaie WB, Abdalla EK, Ahmad SA, Mansfi eld PF. Mide kanseri [Gastric cancer]. In: Alagöl H, Gülçelik MA, Kuru B, translators. M.D. Anderson cerrahi onkoloji el kitabı. İstanbul: Sigma Publishing; 2009. p.205-40 [Feig BW, Berger DH, Fuhrman GM, editors. M.D. Anderson surgical oncology handbook. Philadelphia (PA): Lippincott Williams & Wilkins; 2006].
Wanebo HJ, Kennedy BJ, Winchester DP, Fremgen A, Stewart AK. Gastric carcinoma: does lymph node dissection alter survival? J Am Coll Surg 1996; 183: 616-24.
Shiu MH, Moore E, Sanders M, Huvos A, Freedman B, Goodbold J et al. Infl uence of the extend of resection on survival aft er curative treatment of gastric carcinoma. A retrospective multivariate analysis. Arch Surg 1987; 122: 1347-51.
Ha TK, Jung MS, Lee KH, Lee KG, Kwon SJ. Th e eff ect of adjuvant chemotherapy on stage IV (T4N1-3M0 and T1- 3N3M0) gastric cancer. Cancer Res Treat 2009; 41: 19-23.